UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 171

Sortiert nach

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid

Nutrients, 2018-11, Vol.10 (11), p.1756

2018

Volltextzugriff (PDF)

Neuropilin-1 as Therapeutic Target for Malignant Melanoma

Frontiers in oncology, 2015-06, Vol.5, p.125-125

2015

Volltextzugriff (PDF)

Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth

Nutrients, 2016-11, Vol.8 (11), p.744

2016

Volltextzugriff (PDF)

On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment

Chemotherapy (Basel), 2019-10, Vol.64 (2), p.62-80

2019

Volltextzugriff (PDF)

Growth of Corrole Films from Solution: A Nanometer-Scale Study at the Real Solid–Liquid Interface

Journal of physical chemistry. C, 2021-06, Vol.125 (21), p.11540-11547

2021

Volltextzugriff (PDF)

Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth

Proceedings of the National Academy of Sciences - PNAS, 2012-02, Vol.109 (6), p.2015-2020

2012

Volltextzugriff (PDF)

The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges

Pharmacology & therapeutics (Oxford), 2020-09, Vol.213, p.107579-107579, Article 107579

2020

Volltextzugriff (PDF)

Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin

International journal of cancer, 2015-03, Vol.136 (6), p.E545-E558

2015

Volltextzugriff (PDF)

Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms

International journal of oncology, 2013-07, Vol.43 (1), p.297-306

2013

Volltextzugriff (PDF)

Human Melanoma Cells Secrete and Respond to Placenta Growth Factor and Vascular Endothelial Growth Factor

Journal of investigative dermatology, 2000-12, Vol.115 (6), p.1000-1007

2000

Volltextzugriff (PDF)

Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects

Molecular aspects of medicine, 2023-12, Vol.94, p.101225-101225, Article 101225

2023

Volltextzugriff (PDF)

Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression

British journal of dermatology (1951), 2011-05, Vol.164 (5), p.1061-1070

2011

Volltextzugriff (PDF)

Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity

European journal of cancer (1990), 2008-06, Vol.44 (9), p.1302-1314

2008

Volltextzugriff (PDF)

Vascular endothelial growth factor‐C expression correlates with lymph node localization of human melanoma metastases

Cancer, 2003-08, Vol.98 (4), p.789-797

2003

Volltextzugriff (PDF)

Vascular endothelial growth factor receptor 1 in glioblastoma‑associated microglia/macrophages

Oncology reports, 2020-06, Vol.43 (6), p.2083-2092

2020

Volltextzugriff (PDF)

Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms

International journal of oncology, 2013-07, Vol.43 (1), p.297-306

2013

Volltextzugriff (PDF)

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma

British journal of cancer, 2018-06, Vol.118 (12), p.1596-1608

2018

Volltextzugriff (PDF)

DNA inhibitors for the treatment of brain tumors

Expert opinion on drug metabolism & toxicology, 2020-03, Vol.16 (3), p.195-207

2020

Volltextzugriff (PDF)

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1

Oncotarget, 2017-09, Vol.8 (40), p.66833-66848

2017

Volltextzugriff (PDF)

Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2

Pigment cell and melanoma research, 2015-01, Vol.28 (1), p.73-81

2015

Volltextzugriff (PDF)

Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo

Oncogene, 2017-08, Vol.36 (31), p.4508-4515

2017

Volltextzugriff (PDF)

Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding

Oncotarget, 2016-11, Vol.7 (45), p.72868-72885

2016

Volltextzugriff (PDF)

Silent early migration of a Figulla® septal occluder into the left ventricle

Kardiologia polska, 2017-01, Vol.75 (7), p.724-724

2017

Volltextzugriff (PDF)

Reply to Chakrabarti et al.: Corneal angiogenesis in patients with null FOXC1 variants

Proceedings of the National Academy of Sciences - PNAS, 2012-06, Vol.109 (24), p.E1510-E1510

2012

Volltextzugriff (PDF)

1 – 25 von 171

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(100)
Humans
(82)
Animals
(47)
Biological And Medical Sciences
(47)
Oncology
(43)
Mice
(34)
Medical Sciences
(32)
Cell Biology
(28)
Biochemistry & Molecular Biology
(25)
Tumors
(21)
Cell Line, Tumor
(20)
Pharmacology. Drug Treatments
(20)
Male
(19)
Pharmacology & Pharmacy
(19)
Female
(18)
Fundamental And Applied Biological Sciences. Psychology
(17)
Tumor Cells, Cultured
(17)
Antineoplastic Agents
(15)
Choline Kinase - Antagonists & Inhibitors
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid

Neuropilin-1 as Therapeutic Target for Malignant Melanoma

Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth

On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment

Growth of Corrole Films from Solution: A Nanometer-Scale Study at the Real Solid–Liquid Interface

Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth

The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges

Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1

Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin

Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms

Human Melanoma Cells Secrete and Respond to Placenta Growth Factor and Vascular Endothelial Growth Factor

Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects

Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression

Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity

Vascular endothelial growth factor‐C expression correlates with lymph node localization of human melanoma metastases

Vascular endothelial growth factor receptor 1 in glioblastoma‑associated microglia/macrophages

Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma

DNA inhibitors for the treatment of brain tumors

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1

Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2

Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo

Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding

Silent early migration of a Figulla® septal occluder into the left ventricle

Reply to Chakrabarti et al.: Corneal angiogenesis in patients with null FOXC1 variants

Suchergebnisse filtern